🔗 Visit the ClinicalTrials.gov page for NCT00477906
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Systematic review of medical treatment in melanoma: current status and future prospects. | Oncologist | 2011 | 2.89 |
| 2 | Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine. | J Clin Oncol | 2003 | 1.74 |
| 3 | Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. | Oncoimmunology | 2012 | 1.30 |
| 4 | Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use. | P T | 2012 | 1.19 |
| 5 | Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions. | J Int AIDS Soc | 2015 | 0.78 |
| 6 | Therapeutic cancer vaccines and combination immunotherapies involving vaccination. | Immunotargets Ther | 2014 | 0.75 |